Clinical Decision-Making Flashcards

What is the primary goal of using clinical decision-making frameworks in neurologic practice?

Answer: To make informed, evidence-based decisions tailored to individual patient needs

Clinical decision-making frameworks provide a structured approach for healthcare professionals to integrate the best available research evidence, clinical expertise, and patient values. Their primary goal is to guide the development of individualized, evidence-based treatment plans. This ensures that interventions are tailored to each patient's unique condition, preferences, and circumstances, leading to optimal and effective care.

When assessing a patient with suspected multiple sclerosis (MS), which of the following findings would be most indicative of an acute exacerbation?

Answer: A sudden increase in spasticity

An acute exacerbation, or relapse, in multiple sclerosis (MS) is characterized by new neurological symptoms or a worsening of existing symptoms lasting at least 24 hours, in the absence of fever or infection. A sudden increase in spasticity indicates new inflammation and demyelination in the central nervous system, which is the hallmark of an MS relapse. Other options like stable visual acuity or mood would suggest stability, not an acute exacerbation.

In the context of clinical decision-making for a patient with Parkinson’s disease, which of the following interventions would most likely be recommended to address motor fluctuations?

Answer: Introducing a dopamine agonist medication

Motor fluctuations in Parkinson's disease, such as 'wearing off' or dyskinesias, occur as the effectiveness of levodopa fluctuates throughout the day. Dopamine agonists mimic the effect of dopamine in the brain, providing a more continuous dopaminergic stimulation. This helps to smooth out motor fluctuations, extend 'on' times, and improve overall motor control, making them a key intervention for managing these symptoms.

Which diagnostic tool is most useful for differentiating between a primary brain tumor and a metastatic brain lesion?

Answer: Magnetic Resonance Imaging (MRI) with contrast

Magnetic Resonance Imaging (MRI) with contrast is the most useful diagnostic tool for differentiating between a primary brain tumor and a metastatic brain lesion. MRI provides superior soft tissue resolution compared to CT scans, allowing for detailed visualization of lesion characteristics, surrounding edema, and patterns of enhancement with contrast. These features, along with location and multiplicity, often help distinguish between the two types of tumors.

What is the best approach for managing a patient with chronic migraine who has not responded to first-line pharmacological treatments?

Answer: Consider a second-line medication such as a CGRP inhibitor

For patients with chronic migraine who have not responded to first-line pharmacological treatments, it is appropriate to consider second-line options. CGRP (calcitonin gene-related peptide) inhibitors are a newer class of medications specifically designed to target the CGRP pathway, which plays a crucial role in migraine pathophysiology. They have demonstrated significant efficacy in reducing migraine frequency and severity in patients refractory to other treatments, offering a targeted and effective alternative.